Navigation Links
Sponges as drugs

Dutch researcher Nicole de Voogd has investigated the possibilities for rearing sea sponges in Indonesia. Some of these sponges contain substances of interest to the pharmaceutical industry. As these are increasingly difficult to obtain, there is growing interest in alternative methods of exploitation, such as rearing sponges.

For her research, De Voogd described three new species of sponges and examined the interactions of four sponge species with possible spatial competitors. She discovered that as soon as certain sponge species grow over corals, the coral develops necrotic tissue. From this she concluded that the sponges concerned produce their bioactive substances to defeat spatial competitors. This is important, as in an environment without spatial competitors, such as in a sponge culture, a lower concentration of the substances of interest to the pharmaceutical industry might be produced.

Sponge culture

The researcher tried to rear 9 of the 151 species of sponge observed but was successful with only 3 species. Although the survival rates of these species were generally very high, the growth rates were very slow and unpredictable. Moreover, the reared sponges produced less of the biologically-active substances than their natural counterparts.

Although Indonesia has a very high diversity of sponge species, and therefore a large number of biologically-active substances with pharmaceutical potential, most of the species occur in relatively low densities compared to species in temperate areas. De Voogd discovered that as a result of this low natural density, surprisingly few Indonesian species are suitable for sea rearing.

Sea rearing

Sedentary marine invertebrates such as sponges, are an important source for a large variety of biologically-active substances. Until more advanced techniques such as chemical synthesis, genetic modification and sponge cell culture are realised, rearing in the sea remains the most reliable
'"/>

Source:Netherlands Organization for Scientific Research


Page: 1 2

Related biology news :

1. Researchers identify target for cancer drugs
2. MetaChip provides quick, efficient toxicity screening of potential drugs
3. Newly discovered pathway might help in design of cancer drugs
4. UNC launches study of liver injury caused by drugs
5. UCLA study assesses cost-effectiveness of Hepatitis B drugs
6. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
7. FDA approves more generic AIDS drugs
8. Virginia Tech group adds tools to DNA-targeted anti-cancer drugs
9. Scientists discover that three molecules may be developed into new Alzheimers drugs
10. Scientists to mimic nature for newest cancer drugs
11. Bacteria are key to green plastics, drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sponges drugs

(Date:5/19/2015)... -- Technology is rapidly advancing, outpacing enterprises, ability to secure ... and their management are soon to be rendered obsolete ... as those developed by the FIDO Alliance™. With the ... BYOD, COPE, IoT, and mobile payments, the interconnected online ... In response to the call for seamless, secure, ...
(Date:5/14/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has ... in Smart Mobile Devices " report to their ... a watershed year for fingerprint sensors in smartphones and ... gave fingerprint sensors a raison d,etre in the mobile ... a must-have feature in flagship smartphones. The ...
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS delegation ... had a strong showing at AUVSI,s Unmanned 2015 conference ... of Ohio,s UAS industry met with ... from all points along the UAS ecosystem. ... (DDC) Vice President for Aerospace Rich Knoll . "If ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... farming is the major factor responsible for the destruction ... Indonesia, Malaysia, Thailand, Myanmar, Bangladesh, India, and Sri Lanka, ... of Biogeography. Giri and other researchers used more ... mangrove forests of the region, to quantify the rates ...
... nitrogen fertilizer is believed to benefit the soil by ... scientists dispute this view based on analyses of soil ... before the current practice began. The research, also ... world, was conducted by U of I soil scientists ...
... built at Scripps Institution of Oceanography at UC San ... state of all world oceans simultaneously is approaching its ... network of sensor-bearing profiling floats measures ocean water temperature, ... The Argo Steering Committee, the international panel of scientists ...
Cached Biology News:Study reveals that nitrogen fertilizers deplete soil organic carbon 2Study reveals that nitrogen fertilizers deplete soil organic carbon 3Unprecedented global measurement network achieves full coverage of oceans 2Unprecedented global measurement network achieves full coverage of oceans 3
(Date:5/25/2015)... BOSTON , May 26, 2015  PureTech, a ... toughest health challenges in disruptive ways, announced today that ... Foundation and former CEO of Pearson, has been appointed ... Senior Independent Director and that current Board member ... appointed Board Chairman. Dr. Ben Shapiro , PureTech,s ...
(Date:5/22/2015)... May 22, 2015 According to ... (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide Gel, ... Informatics), by Application & by End User - Global ... is expected to reach around $1.98 Billion by 2020 ... 2015 to 2020. Browse 226 ma ...
(Date:5/21/2015)... Seventh Wave Laboratories, a consulting-based contract ... pharmaceutical products and medical devices, announced the purchase of ... 50,000 sq. ft. building more than three times the ... Facility renovations will begin immediately and the gradual transition ... in September. , “We are excited about this ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
Breaking Biology Technology:PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2
... SuperGen, Inc.,(Nasdaq: SUPG ), a pharmaceutical ... cancer therapies, today announced the company,s plans,to present ... "Molecular,Targets and Cancer Therapeutics" on October 23 and ... and non-clinical advances,in the following compounds: MP-470, SGI-1776 ...
... ... CCR9 for Gastrointestinal Diseases, MOUNTAIN VIEW, Calif., Oct. ... a Phase I clinical trial of CCX025,the company,s fourth ... the chemokine receptor known as CCR9.,Structurally distinct from Traficet-EN(TM) ...
... SUNNYVALE, Calif., Oct. 15 Cepheid (Nasdaq:,CPHD) ... Administration (FDA) categorized,Cepheid,s Xpert(TM) MRSA/SA Skin and ... under the Clinical Laboratory Improvement Amendments,(CLIA). The ... of,Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus,aureus (SA), ...
Cached Biology Technology:SuperGen to Present Data at EORTC-NCI-AACR 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 3ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 4Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 4
... multicolor analysis in a modern flow cytometer, ... that are differentially labeled with fluorescent probes. ... typically used for cell labeling are broader ... a flow cytometers filters. Thus, the fluorescence ...
... kit allows a rapid and efficient ... FLAG-tagged protein. The immunoprecipitation is performed ... a highly specific monoclonal antibody covalently ... of affinity resin allows an efficient ...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
This modular benchtop laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Options include a work bench, ionizaing bar, and air velocity gauge....
Biology Products: